‹ Longevity

Longevity

Peptides: What They Are and What We Don't Know

Speculative. Most peptides sold for healing and longevity are not FDA-approved drugs. The evidence comes mainly from animal studies, and long-term safety in people is unknown.

Not a week goes by without a patient asking me about peptides. Sometimes it starts with a friend at the gym, a podcast or a video online. The question is usually the same: "Should I try BPC-157?"

The honest answer is complicated, and that is exactly why this page exists.

I do not currently prescribe peptides. This page is for education only.

What a peptide is

Peptides are short chains of amino acids, the building blocks of protein. Many act as messengers that tell cells what to do.

That word, "peptide," covers a huge range. Some peptides are well-proven, FDA-approved medicines: insulin is one, and so are the GLP-1 medicines used for diabetes and weight loss. Many others are sold for healing, recovery or longevity with far less proof. Being a peptide does not make something safe or effective. It just describes its shape.

A three-year regulatory roller coaster

To understand where peptides stand today, you have to follow the story with the FDA, because it has changed fast.

In 2023, the FDA placed several popular peptides, including BPC-157, on a list of substances that raise safety concerns for compounding. For many people, that pushed peptides into a gray market of websites selling "research chemicals."

In April 2026, BPC-157 and eleven other peptides were taken off that list. That was not an approval. It simply removed a barrier.

In July 2026, the FDA's compounding advisory committee voted, narrowly, to recommend adding six peptides, including BPC-157 and TB-500, to the list that compounding pharmacies may use. For BPC-157, the vote was 8 to 6. FDA staff had advised against it, and the vote was not binding.1

Then in October 2026, a new HHS policy eased enforcement so that licensed 503A compounding pharmacies can prepare those six peptides with a prescription. It is not FDA approval. It does not add them to the official list. And it does not cover the larger 503B outsourcing facilities.2

So where does that leave us? These peptides are still unapproved and unproven, and access is through licensed 503A compounding pharmacies, not FDA-approved products.

Still, I see this as a very positive step. Bringing peptides out of the gray market and into regulated pharmacies, with a doctor's prescription, means doctors can prescribe them more safely and researchers can study and analyze them properly. That is how we build the evidence we are missing today. This is changing quickly, and I will update this page as it does.

The two my patients ask about

BPC-157 Speculative

BPC-157 was originally derived from a protein found in stomach juice. In animal studies, it has sped healing of tendons, ligaments, muscle and the gut. Part of how it seems to work is by encouraging new blood vessels to grow into injured tissue, a process called angiogenesis. Good human trials are very limited.

TB-500 Speculative

TB-500 is a lab-made fragment of a natural protein called thymosin beta-4. It helps cells move into injured areas and, like BPC-157, encourages new blood vessels. Human data are scarce.

The double-edged sword

Here is the part that keeps me cautious.

Tendons heal slowly partly because they have a poor blood supply. A peptide that grows new blood vessels into an injury sounds like exactly what a tendon needs. And it might be.

But blood vessel growth is driven largely by a signaling system called the VEGF pathway, and that pathway has a dark side. Tumors need blood vessels too. Some of our most important cancer medicines, called anti-VEGF drugs, work by blocking that very pathway, starving tumors of their blood supply.

So consider what that means. Something that pushes blood vessel growth in the opposite direction could, in theory, have effects we do not yet understand. Nobody has shown that it does. But nobody has shown that it does not, either. We simply do not know the long-term side effects.

Purity is the other worry. Products bought online as "research chemicals" are not checked for what they contain. You may not be injecting what the label says. And athletes should know that BPC-157 is banned in tested sports.

GLP-1 microdosing

A newer trend: some people take very small doses of GLP-1 medicines, well below the doses used for weight loss, hoping to lower inflammation or slow aging. This has not been studied in trials. Speculative For the proven uses of these medicines, and their full story, see my GLP-1 page.

More to come

I will add other peptides here over time, each with what the research shows and what we still do not know. If the regulated pharmacies do what I hope, the next few years should finally give us real answers.

References

  1. FDA advisory committee nominates six peptides for pharmacies to compound. National Community Pharmacists Association. July 2026.

  2. Is BPC-157 legal? FDA and HHS status, 2026. Updated November 2026.

General education, not medical advice. Peptides discussed here are not FDA-approved drugs. Do not start any peptide without a doctor who knows your full medical history.